Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher A Ross

Showing results (41-50 of 244) with videos related to

Pageof 25
Sort By:
Journal of Huntington'S Disease|September 13, 2024
Structural MRI Correlates of Anosognosia in Huntington's DiseaseJared T Hinkle, Erin Wildermuth, Xiao J Tong, et al.
The Journal of Biological Chemistry|April 17, 2002
Synphilin-1 is developmentally localized to synaptic terminals, and its association with synaptic vesicles is modulated by alpha-synucleinCátia S Ribeiro, Katia Carneiro, Christopher A Ross, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2011
Factors contributing to institutionalization in patients with Huntington's diseaseAdam Rosenblatt, Brahma V Kumar, Russell L Margolis, et al.
Plos One|October 28, 2015
Sox11 Reduces Caspase-6 Cleavage and ActivityElaine Waldron-Roby, Janine Hoerauf, Nicolas Arbez, et al.
The Journal of Biological Chemistry|August 13, 2002
Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilizationMichelle A Poirier, Huilin Li, Jed Macosko, et al.
Neurobiology of Disease|May 21, 2019
Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptorChelsy R Eddings, Nicolas Arbez, Sergey Akimov, et al.
Journal of Visualized Experiments : Jove|June 26, 2018
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI-Application in Premanifest Huntington's DiseaseDan Wu, Andreia V Faria, Laurent Younes, et al.
Journal of Neuropathology and Experimental Neurology|April 2, 2008
A comparison of huntington disease and huntington disease-like 2 neuropathologyDobrila D Rudnicki, Olga Pletnikova, Jean-Paul G Vonsattel, et al.
Experimental Neurology|December 22, 2007
The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse modelQi Peng, Naoki Masuda, Mali Jiang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 27, 2004
Calmodulin regulates transglutaminase 2 cross-linking of huntingtinGina M Zainelli, Christopher A Ross, Juan C Troncoso, et al.
Pageof 25

Showing results (41-50 of 244) with videos related to

Sort By:
Pageof 25
Journal of Huntington'S Disease|September 13, 2024
Structural MRI Correlates of Anosognosia in Huntington's DiseaseJared T Hinkle, Erin Wildermuth, Xiao J Tong, et al.
The Journal of Biological Chemistry|April 17, 2002
Synphilin-1 is developmentally localized to synaptic terminals, and its association with synaptic vesicles is modulated by alpha-synucleinCátia S Ribeiro, Katia Carneiro, Christopher A Ross, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 4, 2011
Factors contributing to institutionalization in patients with Huntington's diseaseAdam Rosenblatt, Brahma V Kumar, Russell L Margolis, et al.
Plos One|October 28, 2015
Sox11 Reduces Caspase-6 Cleavage and ActivityElaine Waldron-Roby, Janine Hoerauf, Nicolas Arbez, et al.
The Journal of Biological Chemistry|August 13, 2002
Huntingtin spheroids and protofibrils as precursors in polyglutamine fibrilizationMichelle A Poirier, Huilin Li, Jed Macosko, et al.
Neurobiology of Disease|May 21, 2019
Pridopidine protects neurons from mutant-huntingtin toxicity via the sigma-1 receptorChelsy R Eddings, Nicolas Arbez, Sergey Akimov, et al.
Journal of Visualized Experiments : Jove|June 26, 2018
Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI-Application in Premanifest Huntington's DiseaseDan Wu, Andreia V Faria, Laurent Younes, et al.
Journal of Neuropathology and Experimental Neurology|April 2, 2008
A comparison of huntington disease and huntington disease-like 2 neuropathologyDobrila D Rudnicki, Olga Pletnikova, Jean-Paul G Vonsattel, et al.
Experimental Neurology|December 22, 2007
The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse modelQi Peng, Naoki Masuda, Mali Jiang, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 27, 2004
Calmodulin regulates transglutaminase 2 cross-linking of huntingtinGina M Zainelli, Christopher A Ross, Juan C Troncoso, et al.
Pageof 25